LIC Mutual FundEquity Scheme - Sectoral/ Thematic3.1 years
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
Path not in current snapshots
n/a
5 Dec 2024 – 6 May 2026
Trough 28 Feb 2025 · recovered in 432 days
-15.1%
9 Aug 2023 – 8 Nov 2023
Trough 26 Oct 2023 · recovered in 13 days
-6.6%
16 Oct 2024 – 3 Dec 2024
Trough 18 Nov 2024 · recovered in 15 days
-5.5%
23 Feb 2024 – 4 Apr 2024
Trough 13 Mar 2024 · recovered in 22 days
-5.1%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
89
Vs category
100
Consistency
88
Risk-adjusted
81
Drawdown
62
Mean
84
31 Aug 2026 · 24 holdings · top 10 are 62.8%.
Sun Pharmaceutical Industries Ltd
Healthcare
10.1%
Divi's Laboratories Ltd
Healthcare
9.3%
Torrent Pharmaceuticals Ltd
Healthcare
6.5%
Neuland Laboratories Ltd
Healthcare
6.4%
Apollo Hospitals Enterprise Ltd
Healthcare
6.2%
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 15 Sept 2026
Engine status
Healthy
Doing its job
Why this status
Supporting reads
Same-category peers with enough history to inspect beside this fund.
Baroda BNP Paribas Mutual Fund
Caveat: Lower trailing returns
Sundaram Mutual Fund
Caveat: Lower trailing returns
Aditya Birla Sun Life Mutual Fund
Caveat: Deeper drawdown · Lower trailing returns
ICICI Prudential Mutual Fund
Caveat: Deeper drawdown · Lower trailing returns
Kotak Mahindra Mutual Fund
Caveat: Deeper drawdown · Lower trailing returns
LIC Mutual FundEquity Scheme - Sectoral/ Thematic3.1 years
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
NAV
15 Sept 2026 · +14.4% over 1Y
37.1885
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
15 Sept 2026
-3.3%
5 Dec 2024 – 6 May 2026
Trough 28 Feb 2025 · recovered in 432 days
-15.1%
9 Aug 2023 – 8 Nov 2023
Trough 26 Oct 2023 · recovered in 13 days
-6.6%
16 Oct 2024 – 3 Dec 2024
Trough 18 Nov 2024 · recovered in 15 days
-5.5%
23 Feb 2024 – 4 Apr 2024
Trough 13 Mar 2024 · recovered in 22 days
-5.1%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
89
Vs category
100
Consistency
88
Risk-adjusted
81
Drawdown
62
Mean
84
31 Aug 2026 · 24 holdings · top 10 are 62.8%.
Sun Pharmaceutical Industries Ltd
Healthcare
10.1%
Divi's Laboratories Ltd
Healthcare
9.3%
Torrent Pharmaceuticals Ltd
Healthcare
6.5%
Neuland Laboratories Ltd
Healthcare
6.4%
Apollo Hospitals Enterprise Ltd
Healthcare
6.2%
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 15 Sept 2026
Engine status
Healthy
Doing its job
Why this status
Supporting reads